Showing 1 - 2 of 2
Published on 28/08/2024
» Novo Nordisk Pharma (Thailand) Ltd. has signed a Memorandum of Understanding (MOU) with the Faculty of Medicine Siriraj Hospital, Mahidol University. The aim is to promote collaboration in the study and research of medications for diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. This collaboration will also provide opportunities for patients to participate in clinical research and offers researchers more options in clinical studies. Additionally, this partnership also aims to facilitate training, joint research projects, and the exchange of innovative information and knowledge.
Published on 13/12/2022
» SCG expands its portfolio to provide a wider range of solutions to address evolving needs.